Search

Search Results

1. Bilateral Sudden Irreversible Hearing Loss in a Case of Chronic Myeloid Leukaemia: A Case Report

   Chronic myeloid leukemia is a type of blood cancer that affects the bone marrow and results in an overproduction of immature WBCs. The genetic...

   Hafiz Malhan, Enas Dammag, ... Mohammad Bakkar in Indian Journal of Otolaryngology and Head & Neck Surgery

   Article 04 January 2024

2. Is there really an accelerated phase of chronic myeloid leukaemia?

   Robert Peter Gale, Qian Jiang, ... Andreas Hochhaus in Leukemia

   Article Open access 25 June 2024

3. Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia

   In this provocative commentary, we consider several questions posed by the late chronic myeloid leukaemia (CML) expert Prof. Michele Baccarani, which...

   Michele Baccarani, Francesca Bonifazi, ... Robert Peter Gale in Leukemia

   Article Open access 25 March 2022
   

4. SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia

   Objective

   A SARS-CoV-2 Omicron (BA.5.2) epidemic began in China in December, 2022 following stop** the zero COVID policy.

   Methods

   We studied...

   Fang Cheng, Hang **ang, ... Weiming Li in Journal of Cancer Research and Clinical Oncology

   Article 19 June 2023
   

5. The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review

   Background

   Imatinib, a potent inhibitor of targeted protein tyrosine kinases, treats chronic myeloid leukaemia (CML). Data on imatinib-associated...

   Mansour Tobaiqy, Nawal Helmi, ... Sylvia Saade in International Journal of Clinical Pharmacy

   Article 26 December 2023
   

6. Incidence and immunophenotype of abnormal lymphoblast populations at diagnosis of chronic myeloid leukaemia in chronic phase

   Chronic myeloid leukaemia most commonly presents in chronic phase (CML-CP) and it is characterised by granulocytic proliferation. Many patients have...

   Luani Barge, Rebecca Cleary, ... Erin Simleit in Journal of Hematopathology

   Article Open access 10 March 2022
   

7. The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

   Fiona Fernando, Andrew J. Innes, ... Dragana Milojkovic in Bone Marrow Transplantation

   Article 04 April 2023

8. Death due to unsuspected acute myeloid leukaemia: an unusual forensic diagnosis

   Acute myeloid leukaemia (AML) is a rare haematologic cancer with a rapid increase in blast cells, which need to be rapidly diagnosed and treated. The...

   Lila Krebs-Drouot, Georgia Karpathiou, ... Michel Péoc’h in Forensic Science, Medicine and Pathology

   Article 19 August 2022
   

9. Outcomes and prognosis of haploidentical haematopoietic stem cell transplantation in children with FLT3-ITD mutated acute myeloid leukaemia

   The presence of internal tandem duplication mutations in the FMS-like tyrosine kinase 3 receptor ( FLT3-ITD ) is a poor prognostic predictor in...

   Qianwen Shang, Lu Bai, ... **aojun Huang in Bone Marrow Transplantation

   Article 05 March 2024
   

10. Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase

    We interrogated data from 278 consecutive subjects with chronic myeloid leukaemia (CML) presenting in accelerated phase diagnosed by European...

    Sen Yang, **ao-shuai Zhang, ... Qian Jiang in Leukemia

    Article 13 May 2022
    

11. What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?

    Tomas Radivoyevitch, Robert Peter Gale, Matt E. Kalaycio in Leukemia

    Article Open access 10 November 2023
    

12. Survival with chronic myeloid leukaemia after failing milestones

    Therapy after failing response milestones in CML is controversial. Risks associated with comorbidities, drug toxicities or transplantation may...

    Michael Lauseker, Rüdiger Hehlmann, ... Susanne Saußele in Leukemia

    Article Open access 19 September 2023
    

13. External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy

    Feiyang Qi, **aoshuai Zhang, ... Qian Jiang in Leukemia

    Article 29 July 2023
    

14. Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality

    Background

    The introduction of BCR-ABL tyrosine kinase inhibitors (TKIs) to chronic myeloid leukemia (CML) therapy has revolutionized the treatment of...

    Anna Rychter, Joanna Miniszewska, Joanna Góra-Tybor in BioPsychoSocial Medicine

    Article Open access 19 January 2023

15. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study

    Chronic myelomonocytic leukaemia (CMML) is a haematological malignancy with a poor prognosis. Allogeneic haematopoietic stem cell transplantation...

    Shuhei Kurosawa, Yoshimitsu Shimomura, ... Hidehiro Itonaga in Bone Marrow Transplantation

    Article 08 February 2024
    

16. Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC

    We report the results from a multicentre retrospective study of 220 adult patients who underwent allogeneic hematopoietic stem cell transplantation...

    Gaëlle Rey, Elisabeth Daguenet, ... Emmanuelle Tavernier in Bone Marrow Transplantation

    Article 31 August 2023
    

17. Chronic myeloid leukaemia (CML) presenting in B-lymphoblastic crisis: a diagnostic challenge

    We report the case of a 75-year-old female presented with lethargy, Hb 93 g/L, WBC 64 x 10 ⁹ /L, platelet 110 x 10 ⁹ /L. Blood film showed blasts,...

    Ke Xu, Elisabeth Nacheva in Journal of Hematopathology

    Article 11 September 2023
    

18. Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria

    Metabolic reprogramming (MR) influences progression of chronic myeloid leukaemia (CML) to blast crisis (BC), but metabolic programs may change...

    Luciana S. Salaverry, Tomás Lombardo, ... Guillermo A. Blanco in Discover Oncology

    Article Open access 08 July 2022
    

19. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study

    Background

    The advent of chronic myeloid leukaemia (CML) tyrosine-kinase inhibitors (TKI) has led to new paradigms including occupational...

    Cécile Conte, Flora Vayr, ... Fabrice Herin in Supportive Care in Cancer

    Article 18 March 2022
    

20. Pathogenesis and Treatment of Leukemia

    This book covers a comprehensive update on acute and chronic leukemia. In 54 chapters, authors introduce research progress and clinical trials of...

    Harinder Gill, Yok-Lam Kwong

    Book 2023